Hero

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy

About Celyad

Making the Impossible Possible

Celyad is a clinical-stage biopharmaceutical that is developing next generation CAR-T NK cell-based immunotherapies for cancer treatment.

Latest News

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy

Celyad to participate at upcoming healthcare conferences in September

Celyad to participate at upcoming healthcare conferences in September

Celyad Reports First Half 2018 Financial Results and Operational Progress

Celyad Reports First Half 2018 Financial Results and Operational Progress

Discover all news

Carousel

Social Feed

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy. Read… https://t.co/BeWTBsWtvs

1 week ago

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy. Read… https://t.co/BeWTBsWtvs

Celyad to participate at upcoming healthcare conferences in September Read the Press Release https://t.co/H8c1jMrj3q https://t.co/U47WQ3BWCt

2 weeks ago

Celyad to participate at upcoming healthcare conferences in September Read the Press Release https://t.co/H8c1jMrj3q https://t.co/U47WQ3BWCt

Celyad Reports First Half 2018 Financial Results and Operational Progress. Read the full Press Release:… https://t.co/2DcbzIi8S8

3 weeks ago

Celyad Reports First Half 2018 Financial Results and Operational Progress. Read the full Press Release:… https://t.co/2DcbzIi8S8

"Grâce à sa récente levée de fonds ainsi qu’à la signature de plusieurs partenariats, la capacité financière de Cel… https://t.co/mpR3Rg5m5P

1 month ago

"Grâce à sa récente levée de fonds ainsi qu’à la signature de plusieurs partenariats, la capacité financière de Cel… https://t.co/mpR3Rg5m5P

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy. Read… https://t.co/BeWTBsWtvs

1 week ago

Celyad Successfully Doses First Colorectal Cancer Patient with CYAD-01 Following Preconditioning Chemotherapy. Read… https://t.co/BeWTBsWtvs

Celyad to participate at upcoming healthcare conferences in September Read the Press Release https://t.co/H8c1jMrj3q https://t.co/U47WQ3BWCt

2 weeks ago

Celyad to participate at upcoming healthcare conferences in September Read the Press Release https://t.co/H8c1jMrj3q https://t.co/U47WQ3BWCt

Celyad Reports First Half 2018 Financial Results and Operational Progress. Read the full Press Release:… https://t.co/2DcbzIi8S8

3 weeks ago

Celyad Reports First Half 2018 Financial Results and Operational Progress. Read the full Press Release:… https://t.co/2DcbzIi8S8

"Grâce à sa récente levée de fonds ainsi qu’à la signature de plusieurs partenariats, la capacité financière de Cel… https://t.co/mpR3Rg5m5P

1 month ago

"Grâce à sa récente levée de fonds ainsi qu’à la signature de plusieurs partenariats, la capacité financière de Cel… https://t.co/mpR3Rg5m5P